BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38043192)

  • 21. Characterization of the murine high Km glucose transporter GLUT2 gene and its transcriptional regulation by glucose in a differentiated insulin-secreting cell line.
    Waeber G; Thompson N; Haefliger JA; Nicod P
    J Biol Chem; 1994 Oct; 269(43):26912-9. PubMed ID: 7929431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors.
    Son EM; Kim JY; An S; Song KB; Kim SC; Yu E; Hong SM
    J Pathol Transl Med; 2015 Jan; 49(1):30-6. PubMed ID: 25812655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation.
    de Vries C; Konukiewitz B; Weichert W; Klöppel G; Aupperle-Lellbach H; Steiger K
    J Comp Pathol; 2020 Nov; 181():73-85. PubMed ID: 33288156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
    Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
    Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors.
    Kobayashi S; Contractor T; Vosburgh E; Du YN; Tang LH; Clausen R; Harris CR
    Oncogenesis; 2019 Feb; 8(3):16. PubMed ID: 30796198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.
    Hackeng WM; Schelhaas W; Morsink FHM; Heidsma CM; van Eeden S; Valk GD; Vriens MR; Heaphy CM; Nieveen van Dijkum EJM; Offerhaus GJA; Dreijerink KMA; Brosens LAA
    Endocr Pathol; 2020 Jun; 31(2):108-118. PubMed ID: 32103422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and Prognosis.
    Gisder DM; Overheu O; Keller J; Nöpel-Dünnebacke S; Uhl W; Reinacher-Schick A; Tannapfel A; Tischoff I
    Pathobiology; 2023; 90(2):71-80. PubMed ID: 35691289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
    Kim JY; Brosnan-Cashman JA; An S; Kim SJ; Song KB; Kim MS; Kim MJ; Hwang DW; Meeker AK; Yu E; Kim SC; Hruban RH; Heaphy CM; Hong SM
    Clin Cancer Res; 2017 Mar; 23(6):1598-1606. PubMed ID: 27663587
    [No Abstract]   [Full Text] [Related]  

  • 29. Metastatic insulinoma: current molecular and cytotoxic therapeutic approaches for metastatic well-differentiated panNETs.
    Giuroiu I; Reidy-Lagunes D
    J Natl Compr Canc Netw; 2015 Feb; 13(2):139-44. PubMed ID: 25691605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors?
    Wang L; Li G; Bing YT; Tian ML; Wang HY; Yuan CH; Xiu DR
    Chin Med Sci J; 2021 Dec; 36(4):284-294. PubMed ID: 34986965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
    Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
    J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proinsulin-secreting neuroendocrine tumor of the pancreas.
    Piovesan A; Pia A; Visconti G; Terzolo M; Leone A; Magro G; Cesario F; Borretta G
    J Endocrinol Invest; 2003 Aug; 26(8):758-61. PubMed ID: 14669832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment.
    Tanno L; Naheed S; Dunbar J; Tod J; Lopez MA; Taylor J; Machado M; Green B; Ashton-Key M; Chee SJ; Wood O; Pearce NW; Thomas GJ; Friedmann PS; Cave J; Ottensmeier CH
    Neuroendocrinology; 2022; 112(4):370-383. PubMed ID: 34157710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.
    Kim JY; Brosnan-Cashman JA; Kim J; An S; Lee KB; Kim H; Park DY; Jang KT; Oh YH; Hruban RH; Heaphy CM; Hong SM
    Pathology; 2020 Apr; 52(3):336-347. PubMed ID: 32111396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convergence between germline and somatic mutations in pancreatic neuroendocrine tumors.
    Ling C; Hong X; Xu M; Wang Y; Ma X; Cui Y; Jiang R; Cao D; Wu H; Tong A; Zhao Y; Wu W
    Eur J Endocrinol; 2022 May; 187(1):85-90. PubMed ID: 35521758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functioning human insulinomas. An immunohistochemical analysis of intracellular insulin processing.
    Azzoni C; D'Adda T; Tamburrano G; Coscelli C; Madsen OD; Scopsi L; Bordi C
    Virchows Arch; 1998 Dec; 433(6):495-504. PubMed ID: 9870681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience.
    Murakami M; Fujimori N; Matsumoto K; Ohno A; Teramatsu K; Takamatsu Y; Takeno A; Ueda K; Oono T; Ito T; Ogawa Y
    Endocr J; 2022 Oct; 69(10):1201-1209. PubMed ID: 35644576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic neuroendocrine tumors with somatostatin expression and paraganglioma-like features.
    Konukiewitz B; von Hornstein M; Jesinghaus M; Steiger K; Weichert W; Detlefsen S; Kasajima A; Klöppel G
    Hum Pathol; 2020 Aug; 102():79-87. PubMed ID: 32668277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proinsulin Expressing Neuroendocrine Tumors of the Pancreas: An Underrecognized Entity.
    Celli R; Tang LH; Cai G; Freedman-Weiss M; Colunga M; Salem RR; Majumdar S; Jain D
    Pancreas; 2019 Jan; 48(1):55-59. PubMed ID: 30451800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be Underestimated.
    Hwang HS; Kim Y; An S; Kim SJ; Kim JY; Kim SY; Hwang DW; Park DH; Lee SS; Kim SC; Seo DW; Hong SM
    Pancreas; 2018; 47(10):1296-1303. PubMed ID: 30211805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.